Investors
Established in 2000, Bioglobal Limited is an unlisted Australian public company, with the goal of listing on the Australian Securities Exchange in the near future.
Bioglobal’s primary objective is to invest in and commercialise Intellectual Property that will lead to the development of novel and profitable products for the biochemical pest and insect management markets. Bioglobal targets domestic and international market opportunities created by the trend to clean and sustainable products in the fields of crop protection, animal health and consumer products.
To achieve this, Bioglobal:
- Identifies and invests in quality research and development projects, as measured by a range of criteria including market potential, products that are generally recognised as safe (GRAS), profitability, regulatory frameworks and global application.
- Ensures optimal product outcomes through structured management of research and development projects and staged funding based on achievement of technical and commercial milestones.
- Balances the need for products with more immediate revenue generation with research and development of major category products that require longer time frames.
- Adds value to, and maximises, the intellectual property and commercial potential of its product portfolio by forging strong strategic arrangements with premier research institutions and major agrochemical distribution companies respectively.
Bioglobal Limited
ABN 94 091 488 505
ACN 091 488 505
Principal and Registered Office
Bioglobal Ltd
12 Electronics Street, Eight Mile Plains 4113,
Queensland, Australia
Phone: +61 7 3340 9999
Fax: +61 7 3340 9900
Company Directors & Officers
Mr Hugh Nalder, Chairman
Mr Stephen Sexton, Executive Director
Mr David Grace, Director
Lawyers
Cooper Grace Ward
Level 21, 400 George Street, Brisbane, QLD
Auditors
Elliot Partners
Level 11, 87 Wickham Terrace, Spring Hill, QLD
Patent & Trademark Attorney
IP Gateway Patent & Trademark Attorneys
Suite 2, 18 Carol Avenue, Springwood, QLD
|
